Toxicological effects of a cationic clay, montmorillonite in vitro and in vivo

Swartzen-Allen, S. L. & Matijevic, E. Surface and colloid chemistry of clays. Chem Revs 74:74385–74400 (1974).

Tomas, F. et al. Layer charge and eletrophoretic mobility of smectites. Colloids Surf 159:351–358 (1999).

Lee, W. F. & Fu, Y. T. Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. Appl Polym Scl 89:3652–3660 (2003).

Komine, H. Simplified evaluation for swelling characteristics of bentonites. Eng Geol 71:256–279 (2004).

Aguzzi, C. C., Cerezo, P., Viseras, C. & Caramella, C. Use of clays as drug delivery systems: Possibilities and limitations. Appl Clay Sci 36:22–36 (2007).

Ramos, A. J. & Hernández, E. In vitro aflatoxin adsorption by means of a montmorillonite silicate. A study of adsorption isotherms. Anim Feed Sci Technol 62: 263–269 (1996).

Zheng, J. P., Luan, L., Wang, H. Y., Xi, L. F. & Yao, K. D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci 36: 297–301 (2007).

Fudala, A. A., Pálinkó, I. & Kiricsi, I. Preparation and characterization of hybrid organic-inorganic composite materials using the amphoteric property of amino acids: amino acid intercalated layered double hydroxide and montmorillonite. Inorg Chem 38:4653–4658 (1999).

Kollár, T., Pálinkó, I., Kónya, Z. & Kiricsi, I. Intercalating amino acid guests into montmorillonite host. J Mol Struct 651–653:335–340 (2003).

Jin, F. H. et al. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23:1981–1987 (2002).

Park, J. K. et al. Controlled release of donepezil intercalated in smectite clays. Int J Pharm 359:198–204 (2008).

Jung, H., Kim, H. M., Choy, Y. B., Hwang, S. J. & Choy, J. H. Itraconazole-Laponite: Kinetics and mechanism of drug release. Appl Clay Sci 40:99–107 (2008).

Jung, H., Kim, H. M., Choy, Y. B., Hwang, S. J. & Choy, J. H. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconzaole. Int J Pharm 349:283–290 (2008).

Yu, J., Baek, M., Chung, H. E. & Choi, S. J. Physicochemical properties affecting the potential in vitro cytotoxicity of inorganic layered nanoparticles. Toxicol Environ Health Sci 2:149–152 (2010).

Murphy, E. J., Roberts, E. & Horrocks, L. A. Aluminum silicate toxicity in cell cultures. Neuroscience 55:597–605 (1993).

Lee, Y. H. et al. Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model. Biomed Eng Appl Basis Comm 17:12–18 (2005).

Herzog, E. et al. A new approach to the toxicity testing of carbon-based nanomaterials-The clonogenic assay. Toxicol Lett 174:49–60 (2007).

Baek, M. et al. Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge. J Phys Conf Ser 304:1–7 (2011).

kallifatidis, G. et al. Sulforaphane increases drug-modiated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 19:188–195 (2011).

Lliescu, R. I., Andronescu, E., Voicu, G., Ficai, A. & Covaliu, C. I. Hybrid materials based on montmorillonite and citostatic drugs: Preparation and charctrization. Appl Clay Sci 52:62–68 (2011).

Dong, Y. & Feng, S. S. Poly (D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:6068–6076 (2005).

Lambert, J. D., Sang, S., Hong, J. & Yang, C. S. Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (−)-epigallocatechin-3-gallate. J Agric Food Chem 58:10016–10019 (2010)

Chung, H. E., Kim, I. S., Baek, M., Yu, J. & Choi, S. J. Long-term cytotoxicity potential of anionic nanoclays in human cells. Toxicol Environ Health Sci 3:129–133 (2011).